Sleep apnea and galectin-3: possible sex-specific relationship
- PMID: 30721387
- PMCID: PMC6761033
- DOI: 10.1007/s11325-019-01788-5
Sleep apnea and galectin-3: possible sex-specific relationship
Abstract
Purpose: Sleep apnea is associated with increased risk of cardiovascular disease. Elevated plasma galectin-3 levels, a biomarker associated with myocardial fibrosis, are also associated with adverse cardiovascular events, including heart failure. Our objective was to determine the relationship between severity of sleep apnea and plasma levels of galectin-3 and to determine whether this relationship was modified by sex.
Methods: We performed a cross-sectional study of 471 Mexican Americans from Starr County, TX who underwent an overnight, in-home sleep evaluation, and plasma measurement of galectin-3. Severity of sleep apnea was based on apnea hypopnea index (AHI). Multivariable linear regression modeling was used to determine the association between categories of sleep apnea and galectin-3. We also tested for interactions by sex.
Results: The mean age was 53 years, and 74% of the cohort was female. The prevalence of moderate to severe sleep apnea (AHI > 15 apnea-hypopnea events per hour) was 36.7%. Moderate to severe sleep apnea was associated with increased levels of galectin-3 in the entire population, but we identified a statistically significant interaction between galectin-3 levels and category of sleep apnea by sex (p for interaction = 0.02). Plasma galectin levels were significantly higher in women with moderate or severe sleep apnea than women with no/mild sleep apnea (multivariable adjusted p < 0.001), but not in men (p = 0.5).
Conclusions: Sleep apnea is associated elevated galectin-3 levels in women but not men. Our findings highlight a possible sex-specific relationship between sleep apnea and galectin-3, a biomarker of potential myocardial fibrosis that has been associated with increased cardiovascular risk.
Keywords: Galectin-3; High-sensitivity troponin; Sleep apnea.
Conflict of interest statement
Conflicts of interest
The authors declare that they have no conflicts of interest.
Figures
Similar articles
-
Relationships between sleep apnea, cardiovascular disease risk factors, and aortic pulse wave velocity over 18 years: the Wisconsin Sleep Cohort.Sleep Breath. 2016 May;20(2):813-7. doi: 10.1007/s11325-015-1181-3. Epub 2015 Apr 26. Sleep Breath. 2016. PMID: 25913148 Free PMC article.
-
Factors associated with postoperative exacerbation of sleep-disordered breathing.Anesthesiology. 2014 Feb;120(2):299-311. doi: 10.1097/ALN.0000000000000041. Anesthesiology. 2014. PMID: 24158050
-
Varying Hypopnea Definitions Affect Obstructive Sleep Apnea Severity Classification and Association With Cardiovascular Disease.J Clin Sleep Med. 2018 Dec 15;14(12):1987-1994. doi: 10.5664/jcsm.7520. J Clin Sleep Med. 2018. PMID: 30518445 Free PMC article.
-
[Sleep apnea syndromes and cardiovascular disease].Bull Acad Natl Med. 2005 Mar;189(3):445-59; discussion 460-4. Bull Acad Natl Med. 2005. PMID: 16149210 Review. French.
-
Unlocking the role of Galectin-3: Implications for sleep disorders and health.Sleep Med. 2024 Dec;124:110-114. doi: 10.1016/j.sleep.2024.09.016. Epub 2024 Sep 13. Sleep Med. 2024. PMID: 39288581 Review.
Cited by
-
Association Between Sleep Disordered Breathing and Left Ventricular Function: A Cross-Sectional Analysis of the ECHO-SOL Ancillary Study.Circ Cardiovasc Imaging. 2020 May;13(5):e009074. doi: 10.1161/CIRCIMAGING.119.009074. Epub 2020 May 15. Circ Cardiovasc Imaging. 2020. PMID: 32408831 Free PMC article.
-
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents.Eur Respir Rev. 2022 Apr 13;31(164):210269. doi: 10.1183/16000617.0269-2021. Print 2022 Jun 30. Eur Respir Rev. 2022. PMID: 35418489 Free PMC article.
-
Sex-specific associations of cardiorespiratory fitness and galectin-3 in the general population.ESC Heart Fail. 2022 Dec;9(6):4240-4249. doi: 10.1002/ehf2.14151. Epub 2022 Sep 16. ESC Heart Fail. 2022. PMID: 36113868 Free PMC article.
-
Changes in Left Heart Geometry, Function, and Blood Serum Biomarkers in Patients with Obstructive Sleep Apnea after Treatment with Continuous Positive Airway Pressure.Medicina (Kaunas). 2022 Oct 24;58(11):1511. doi: 10.3390/medicina58111511. Medicina (Kaunas). 2022. PMID: 36363468 Free PMC article.
-
Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center.Diagnostics (Basel). 2025 Feb 5;15(3):375. doi: 10.3390/diagnostics15030375. Diagnostics (Basel). 2025. PMID: 39941305 Free PMC article.
References
-
- Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, Andre S, Crijns HJ, Gabius HJ, Maessen J, Pinto YM (2004) Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110 (19):3121–3128. doi:10.1161/01.CIR.0000147181.65298.4D - DOI - PubMed
-
- Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E (2014) Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study. Am Heart J 167 (5):674–682 e671. doi:10.1016/j.ahj.2013.12.031 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical